Home- Research
- Conferences
- Workshops & Training
- Program
- Overview
- *Innovation Cafe
- Drug Safety
- Counterfeit Drugs
- Valuation & Auditing
- Drug Discovery Innovation
- Drug Development
- Complex Systems & Org. Development
- Semantic Web
- R&D Knowledge Management
- Abstracts
- Speakers
- Allemand, P
- Barrett, J
- Gardner, S
- Gates, P
- Gibbs, A
- Hardy, B
- Henrick, K
- Jautelat, R
- Jordis, U
- Kanagy, J
- Liebman, M
- Montano, B
- Newman, V
- Polsky-Newman, R
- Scoffin, R
- Sharp, M
- Spitzner, J
- Starry, S
- Weintraub, H
- Wikel, J
- Molecular Medicine
- Nanobiotech
- Personalised Medicine
- Exhibition
- Registration
- About
- Overview
- Contact
- Support
- Schedule
|
|
|
|
|
|
|
|
|
| Herschel Weintraub, CambridgeSoft, Philadelphia meeting chair |
|
Herschel J.R. Weintraub received his Ph.D. in Macromolecular Science from CaseWestern Reserve University in 1975. He also holds a B.S. in Biomedical Engineering from Case Institute of Technology. Following postdoctoral research in Medicinal Chemistry at the Purdue University School of Pharmacy, he served on the faculty of the Department of Medicinal Chemistry and Pharmacognosy at Purdue as an Assistant Professor of Medicinal Chemistry. In 1978, he was awarded a USPHS National Library of Medicine Fellowship in Computer Science at the University of Illinois. Dr. Weintraub maintained his appointment at Purdue until 1982, when he joined the Lilly Research Laboratories as Senior Physical Chemist. He subsequently joined the Computer-Assisted Molecular Design group at Abbott Laboratories, and in 1986 established the Theoretical Chemistry Department at Merrell Dow Pharmaceuticals (now Aventis). During the period from 1986 until 1993, as Head of Global Theoretical Chemistry and Scientific Supercomputing, Herschel was instrumental in the acquisition of graphics systems, major modeling software, and a Cray Supercomputer for Molecular Design and Structural Chemistry applications. In 1993, Dr. Weintraub moved to the R.W. Johnson Pharmaceutical Research Institute as Assistant Director of Discovery Research, Computer-Assisted Drug Discovery. In 1997, Herschel accepted the position of Vice President, Computational Chemistry and Informatics, at Helios Pharmaceuticals in Louisville, Kentucky. He then served as Director of Scientific Computing at Genentech, Inc. in South San Francisco, California until 2001. After working as an independent consultant in the area of Pharmaceutical and Biotech R&D Informatics and Molecular Modeling, Herschel joined IBM Life Sciences as a Principal. In mid-2005 he assumed the position of Director, Major Accounts at CambridgeSoft, Inc.
Dr. Weintraub is the author of CAMSEQ ® , developed in 1973 as the first commercial molecular modeling application for "small molecule" drug design, and CAMSEQ/M, a PC-based graphical molecular modeling program, developed in 1979.
Dr. Weintraub is the author of over 30 scientific publications, including 6 book chapters on subjects related to molecular modeling and drug design. His research interests lie in the areas of Pharmaceutical Informatics, Computer-Assisted Drug Discovery, Structural Chemistry, Combinatorial Chemistry and Diversity, and applications development in these fields. He is past chair of the Gordon Conference on QSAR.
He is also an associate faculty member in the Molecular Design Institute of the University of California at San Francisco and serves on the Advisory Board of Current Drug Discovery.
|
|
|
|
|
|
|
|
|
|
|
